Multi-cancer blood tests like Galleri are gaining attention for their ability to detect cancers without routine screening.

As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support for its use is building.

The ability of Raman spectroscopy to identify molecular-level spectral fingerprints has made it an attractive route to diagnostic information and identification of early-stage tumors, especially in ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

"My message to parents is that if you notice something, do something," the mom told Newsweek after her twins were diagnosed ...

In Estonia, breast cancer screening is offered from the age of 50, yet one-fifth of first diagnoses occur in younger women. A new clinical study has therefore been conducted to test better ways to ...

Linking nanopores with nanofluidic chips can slow molecules, cut noise, scale measurements, and enable early disease ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...